Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-79.43%
↓ 311% below average
Average (6y)
-19.32%
Historical baseline
Range
High:-4.11%
Low:-79.43%
CAGR
+54.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -79.43% | -277.7% |
| 2023 | -21.03% | -34.6% |
| 2022 | -15.62% | -249.9% |
| 2021 | -4.46% | -8.7% |
| 2020 | -4.11% | +13.4% |
| 2019 | -4.74% | +18.8% |
| 2018 | -5.84% | - |